Literature DB >> 18459048

Rapid development and optimization of tablet manufacturing using statistical tools.

Eutimio Gustavo Fernández1, Silvia Cordero, Malvina Benítez, Iraelio Perdomo, Yohandro Morón, Ada Esther Morales, Milagros Gaudencia Arce, Ernesto Cuesta, Juan Lugones, Maritza Fernández, Arturo Gil, Rodolfo Valdés, Mirna Fernández.   

Abstract

The purpose of this paper was to develop a statistical methodology to optimize tablet manufacturing considering drug chemical and physical properties applying a crossed experimental design. The assessed model drug was dried ferrous sulphate and the variables were the hardness and the relative proportions of three excipients, binder, filler and disintegrant. Granule properties were modeled as a function of excipient proportions and tablet parameters were defined by the excipient proportion and hardness. The desirability function was applied to achieve optimal values for excipient proportions and hardness. In conclusion, crossed experimental design using hardness as the only process variable is an efficient strategy to quickly determine the optimal design process for tablet manufacturing. This method can be applied for any tablet manufacturing method.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18459048      PMCID: PMC2976958          DOI: 10.1208/s12249-008-9095-z

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  9 in total

1.  Multivariate methods in developing an evolutionary strategy for tablet formulation.

Authors:  J Gabrielsson; A Nyström; T Lundstedt
Journal:  Drug Dev Ind Pharm       Date:  2000-03       Impact factor: 3.225

Review 2.  Process control and scale-up of pharmaceutical wet granulation processes: a review.

Authors:  A Faure; P York; R C Rowe
Journal:  Eur J Pharm Biopharm       Date:  2001-11       Impact factor: 5.571

3.  Note on the measurement of flowability according to the European Pharmacopoeia.

Authors:  Andrea Schüssele; Annette Bauer-Brandl
Journal:  Int J Pharm       Date:  2003-05-12       Impact factor: 5.875

4.  Study of formulation variables influencing the drug release rate from matrix tablets by experimental design.

Authors:  Sandra Furlanetto; Marzia Cirri; Francesca Maestrelli; Giovanna Corti; Paola Mura
Journal:  Eur J Pharm Biopharm       Date:  2005-09-08       Impact factor: 5.571

5.  Experimental design for a pharmaceutical formulation: optimisation and robustness.

Authors:  B Campisi; D Chicco; D Vojnovic; R Phan-Tan-Luu
Journal:  J Pharm Biomed Anal       Date:  1998-10       Impact factor: 3.935

6.  Optimization of poorly compactable drug tablets manufactured by direct compression using the mixture experimental design.

Authors:  Tiago Martinello; Telma Mary Kaneko; Maria Valéria Robles Velasco; Maria Elena Santos Taqueda; Vladi O Consiglieri
Journal:  Int J Pharm       Date:  2006-05-24       Impact factor: 5.875

7.  Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology.

Authors:  Yaw-Bin Huang; Yi-Hung Tsai; Shu-Hui Lee; Jui-Sheng Chang; Pao-Chu Wu
Journal:  Int J Pharm       Date:  2004-12-25       Impact factor: 5.875

8.  Once-daily propranolol extended-release tablet dosage form: formulation design and in vitro/in vivo investigation.

Authors:  Yaw-Bin Huang; Yi-Hung Tsai; Wan-Chiech Yang; Jui-Sheng Chang; Pao-Chu Wu; Kozo Takayama
Journal:  Eur J Pharm Biopharm       Date:  2004-11       Impact factor: 5.571

9.  Formulation design of carbamazepine fast-release tablets prepared by melt granulation technique.

Authors:  Beatrice Perissutti; Fulvio Rubessa; Mariarosa Moneghini; Dario Voinovich
Journal:  Int J Pharm       Date:  2003-04-30       Impact factor: 5.875

  9 in total
  1 in total

1.  Fractional iron absorption from enteric-coated ferrous sulphate tablet.

Authors:  Prashanth Thankachan; Beena Bose; Rajarajan Subramanian; Raju Koneri; Anura V Kurpad
Journal:  Indian J Med Res       Date:  2020-04       Impact factor: 2.375

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.